Renal Cell Cancer |
Renal cell carcinoma |
Recent Blog Posts
View Post: RENAL CELL CARCINOMA
11 Nov 2009 by creativelivenew
Bevacizumab, sorafenib and temsirolimus are not recommended as first drug treatments for people with advanced and/or metastatic renal cell carcinoma. ... TROGLODYTE 7 Mar 2004 ... Papillary renal cell carcinoma: A type of kidney cancer ...
View Blog: BookViet4a.Org - http://bookviet4a.org/
View Post: Advances in Surgery for Renal Cell Cancer: Robot-assisted ...
19 Nov 2009 by tracey
For patients diagnosed with for renal cell cancer (RCC), or kidney cancer, surgery is often the mainstay of treatment. In addition to traditional open surgery for the disease, a less extensive and invasive alternative exists: ...
View Blog: CancerConsultants - http://www.cancerconsultants.com/
View Post: Glycemic index, glycemic load and renal cell carcinoma risk ...
27 Oct 2009 by Galeone, C., Pelucchi, C., Maso, LD, Negri,...
Key words: cancer risk, case–control studies, diet, glycemic index, glycemic load, renal cell carcinoma. Received for publication November 26, 2008. Revision received March 6, 2009. Accepted for publication March 9, 2009. ...
View Blog: Annals of Oncology - recent issues - http://annonc.oxfordjournals.org/
View Post: 'FlashForward': Renal cell carcinoma and Bob Dylan
19 Nov 2009 by Josh Lasser
What we didn't know before tonight, though, was that four weeks before the blackout Bryce learned that his stage four renal cell carcinoma had metastasized. Bad news? Yes. Worth ruining someone else's '63 T-Bird? No. ...
View Blog: It Happened Last Night - http://blog.zap2it.com/ithappenedlastnight/
View Post: What makes skin cancer grow
22 Nov 2009 by Ani
... colonctrials enoxaparin thromboprophylaxis in cancer ppl w/ elev8d tissue factor baring microparticles http://bit.ly/8yANMn; colonctrials bortezomib & bvacizumab in ppl w/ advanced or recurrent renal cell cancer http://bit.ly/88A5OQ ...
View Blog: Health News - http://blog.taragana.com/health/
View Post: News Article : New Angiogenesis Inhibitor Approved for Renal Cell ...
24 Oct 2009 by Cheryl A. Thompson
The most commonly reported adverse events in patients with advanced renal cell carcinoma who received pazopanib during a randomized study were diarrhea, hypertension, hair color change, nausea, anorexia, and vomiting. ...
View Blog: ASHP Health-System Pharmacy News - http://www.ashp.org/Import/NEWS/HealthSystemPharmacyNews.aspx

Not Signed In -

